Evaluation of the new active Cydia Pomonella Granulosis Virus Strain V22 in the Product Grandex Biological Insecticide

This consultation closed on 11 August 2015.
Consultation period: 
14 July 2015 to 11 August 2015

The APVMA is considering an application for the registration of a new product containing the new active constituent Cydia Pomonella Granulovirus Strain C22 (CpGV-V22). The product, Grandex Biological Insecticide is to be registered as a biological agent to control codling moth and oriental fruit moth in pome and stone fruits.

We invite comment from 14 July 2015 to 11 August 2015 on whether the application for registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety

Download the Public Release Summary on the evaluation of the new active Cydia Pomonella Granulosis Virus Strain V22 in the Product Grandex Biological Insecticide.

For more information, see APVMA Gazette Notice (page 18) from 14 July 2015.

Please send your written submission by email, post or fax to:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Email: enquiries@apvma.gov.au
Fax: +61 2 6210 4741

For enquiries, please call +61 2 6210 4701.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.